Adjuvant Aromatase Inhibitor Options in Overweight and Obese Postmenopausal Women with Breast Cancer

Muhammad Younus, Michelle Kissner, Lester Reich, Nicola Wallis, Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature. Drug Safety. ,vol. 34, pp. 1125- 1149 ,(2011) , 10.2165/11594170-000000000-00000

J Geisler, Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance? British Journal of Cancer. ,vol. 104, pp. 1059- 1066 ,(2011) , 10.1038/BJC.2011.58

Melinda Protani, Michael Coory, Jennifer H. Martin, Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis Breast Cancer Research and Treatment. ,vol. 123, pp. 627- 635 ,(2010) , 10.1007/S10549-010-0990-0

Youfa Wang, May A. Beydoun, Lan Liang, Benjamin Caballero, Shiriki K. Kumanyika, Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity. ,vol. 16, pp. 2323- 2330 ,(2008) , 10.1038/OBY.2008.351

M Seifert, M Stierer, P Dubsky, R Greil, G Steger, H Samonigg, C Fesl, R Jakesz, The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial British Journal of Cancer. ,vol. 109, pp. 589- 596 ,(2013) , 10.1038/BJC.2013.367

Federica Cuppone, Emilio Bria, Sunil Verma, Kathleen I. Pritchard, Sonal Gandhi, Paolo Carlini, Michele Milella, Cecilia Nisticò, Edmondo Terzoli, Francesco Cognetti, Diana Giannarelli, Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials. Cancer. ,vol. 112, pp. 260- 267 ,(2008) , 10.1002/CNCR.23171

Amr A. Azim, Maria Costantini-Ferrando, K. Lostritto, Kutluk Oktay, Relative Potencies of Anastrozole and Letrozole to Suppress Estradiol in Breast Cancer Patients Undergoing Ovarian Stimulation before in Vitro Fertilization The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 2197- 2200 ,(2007) , 10.1210/JC.2007-0247

Rowan Chlebowski, Jack Cuzick, Dereck Amakye, Ingo Bauerfeind, Aman Buzdar, Stephen Chia, Bruno Cutuli, Rick Linforth, Nicolaì Maass, Shinzaburo Noguchi, André Robidoux, Sunil Verma, Peyman Hadji, Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer The Breast. ,vol. 18, ,(2009) , 10.1016/S0960-9776(09)70002-5

PE Goss, JN Ingle, J-AW Chapman, MJ Ellis, GW Sledge, GT Budd, M Rabaglio, K Gelmon, L Shepherd, KI Pritchard, Abstract S1-1: Final Analysis of NCIC CTG MA.27: A Randomized Phase III Trial of Exemestane Versus Anastrozole in Postmenopausal Women with Hormone Receptor Positive Primary Breast Cancer Cancer Research. ,vol. 70, ,(2010) , 10.1158/0008-5472.SABCS10-S1-1

Marianne Ewertz, Maj-Britt Jensen, Katrín Á. Gunnarsdóttir, Inger Højris, Erik H. Jakobsen, Dorte Nielsen, Lars E. Stenbygaard, Ulla B. Tange, Søren Cold, Effect of Obesity on Prognosis After Early-Stage Breast Cancer Journal of Clinical Oncology. ,vol. 29, pp. 25- 31 ,(2011) , 10.1200/JCO.2010.29.7614